# A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients

> **NCT00905268** · PHASE3 · COMPLETED · sponsor: **Santhera Pharmaceuticals** · enrollment: 232 (actual)

## Conditions studied

- Friedreich's Ataxia

## Interventions

- **DRUG:** idebenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00905268
- **Lead sponsor:** Santhera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2016-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905268, "A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00905268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*